Delivery Order SPE2DB22D2108-SPE2DB25FU4PY
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a prescription neurological medication, with a ceiling value of $1,668.35 and a period of performance through May 29, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Trokendi XR 100 mg capsules, a neurological medication, with a ceiling value of $2,319.31. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The contract has a ceiling value of $1,949.13 and an ultimate completion date of February 2, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Trokendi XR 200 mg capsules, with a ceiling value of $3,366.60 and an ultimate completion date of May 13, 2024. The contract type is Firm Fixed Price. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 25 mg capsules, a neurological medication, with a ceiling value of $8,079.37 and a period of performance through April 17, 2025. The contract is not set-aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,262.75, is for the delivery of Trokendi XR 50 mg capsules. The contract has an ultimate completion date of July 3, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,640.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a medication used to treat certain neurological conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,109.27 delivery order is for the supply of Trokendi XR 200 mg capsules, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of May 13, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,592.37, is for the delivery of Trokendi XR 50 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a completion date of April 29, 2025. The contract is not set aside and was awarded on April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The award, valued at $5,966.46, has a firm fixed price and an ultimate completion date of May 1, 2024. The contract is not designated with a set-aside. AmerisourceBergen maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...